GRANTLEY ITTERA: Open Payments
NPI 1619223666 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,702 in 174 payments from 19 companies in 2025. Trend: 2023 $3,408 · 2024 $3,672 · 2025 $3,702
Food & beverage: $3,702
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $701 |
| ABBVIE INC. | 21 | $423 |
| E.R. Squibb & Sons, L.L.C. | 12 | $362 |
| Janssen Pharmaceuticals, Inc | 20 | $360 |
| Vanda Pharmaceuticals Inc. | 16 | $345 |
| Otsuka America Pharmaceutical, Inc. | 18 | $303 |
| Alkermes, Inc. | 16 | $300 |
| Neurocrine BioSciences, Inc. | 17 | $292 |
| Teva Pharmaceuticals USA, Inc. | 15 | $284 |
| Axsome Therapeutics, Inc. | 3 | $84 |
Products named: CAPLYTA, VRAYLAR, COBENFY, INGREZZA, FANAPT, SPRAVATO, REXULTI, ARISTADA.
Industry payments across FL — which companies pay providers there.
